Early clinical experience with leflunornide in uveitis

被引：15

作者：

Roy, Mili ^{[1
]}

机构：

[1] Univ Manitoba, Dept Ophthalmol, Winnipeg, MB, Canada

来源：

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE | 2007年 / 42卷 / 04期

关键词：

D O I：

10.3129/i07-085

中图分类号：

R77 [眼科学];

学科分类号：

100212 [眼科学];

摘要：

引用

页码：634 / 634

页数：1

共 5 条

[1]

Baughman RP, 2004, SARCOIDOSIS VASC DIF, V21, P43

[2]

DESCHENES JD, 1997, DUANES FDN CLIN OPHT, P1

[3]

The effects of leflunomide on clinical parameters and serum levels of IL-6, IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis [J].

Litinsky, I ;

Paran, D ;

Levartovsky, D ;

Wigler, I ;

Kaufman, I ;

Yaron, I ;

Yaron, M ;

Caspi, D ;

Elkayam, O .

CYTOKINE, 2006, 33 (02) :106-110

[4]

LEFLUNOMIDE - INHIBITION OF S-ANTIGEN INDUCED AUTOIMMUNE UVEITIS IN LEWIS RATS [J].

ROBERTSON, SM ;

LANG, LS .

AGENTS AND ACTIONS, 1994, 42 (3-4) :167-172

[5]

Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide -: Involvement of impaired integrin activation and immunologic synapse formation [J].

Zeyda, M ;

Poglitsch, M ;

Geyeregger, R ;

Smolen, JS ;

Zlabinger, GJ ;

Hörl, WH ;

Waldhäusl, W ;

Stulnig, TM ;

Säemann, MD .

ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2730-2739

← 1 →